Literature DB >> 26705509

Selecting, Acquiring, and Using Small Molecule Libraries for High-Throughput Screening.

Sivaraman Dandapani1, Gerard Rosse2, Noel Southall3, Joseph M Salvino4, Craig J Thomas3.   

Abstract

The selection, acquisition and use of high quality small molecule libraries for screening is an essential aspect of drug discovery and chemical biology programs. Screening libraries continue to evolve as researchers gain a greater appreciation of the suitability of small molecules for specific biological targets, processes and environments. The decisions surrounding the make-up of any given small molecule library is informed by a multitude of variables and opinions vary on best-practices. The fitness of any collection relies upon upfront filtering to avoiding problematic compounds, assess appropriate physicochemical properties, install the ideal level of structural uniqueness and determine the desired extent of molecular complexity. These criteria are under constant evaluation and revision as academic and industrial organizations seek out collections that yield ever improving results from their screening portfolios. Practical questions including cost, compound management, screening sophistication and assay objective also play a significant role in the choice of library composition. This overview attempts to offer advice to all organizations engaged in small molecule screening based upon current best practices and theoretical considerations in library selection and acquisition.

Entities:  

Year:  2012        PMID: 26705509      PMCID: PMC4687755          DOI: 10.1002/9780470559277.ch110252

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  100 in total

Review 1.  Target-oriented and diversity-oriented organic synthesis in drug discovery.

Authors:  S L Schreiber
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

2.  A new approach to finding natural chemical structure classes.

Authors:  Jun Xu
Journal:  J Med Chem       Date:  2002-11-21       Impact factor: 7.446

Review 3.  Enhancements of screening collections to address areas of unmet medical need: an industry perspective.

Authors:  David H Drewry; Ricardo Macarron
Journal:  Curr Opin Chem Biol       Date:  2010-04-21       Impact factor: 8.822

4.  In silico prediction of drug solubility: 4. Will simple potentials suffice?

Authors:  Kai Lüder; Lennart Lindfors; Jan Westergren; Sture Nordholm; Rasmus Persson; Mikaela Pedersen
Journal:  J Comput Chem       Date:  2009-09       Impact factor: 3.376

5.  Compound Management for Quantitative High-Throughput Screening.

Authors:  Adam Yasgar; Paul Shinn; Ajit Jadhav; Douglas Auld; Sam Michael; Wei Zheng; Christopher P Austin; James Inglese; Anton Simeonov
Journal:  JALA Charlottesv Va       Date:  2008-04

6.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

7.  Targeted covalent drugs of the kinase family.

Authors:  Juswinder Singh; Russell C Petter; Arthur F Kluge
Journal:  Curr Opin Chem Biol       Date:  2010-07-06       Impact factor: 8.822

8.  A specific mechanism for nonspecific activation in reporter-gene assays.

Authors:  Douglas S Auld; Natasha Thorne; Dac-Trung Nguyen; James Inglese
Journal:  ACS Chem Biol       Date:  2008-07-01       Impact factor: 5.100

9.  Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.

Authors:  Wenjun Zhou; Dalia Ercan; Liang Chen; Cai-Hong Yun; Danan Li; Marzia Capelletti; Alexis B Cortot; Lucian Chirieac; Roxana E Iacob; Robert Padera; John R Engen; Kwok-Kin Wong; Michael J Eck; Nathanael S Gray; Pasi A Jänne
Journal:  Nature       Date:  2009-12-24       Impact factor: 49.962

Review 10.  Rational methods for the selection of diverse screening compounds.

Authors:  David J Huggins; Ashok R Venkitaraman; David R Spring
Journal:  ACS Chem Biol       Date:  2011-02-15       Impact factor: 5.100

View more
  15 in total

1.  Synergistic Effects of Stereochemistry and Appendages on the Performance Diversity of a Collection of Synthetic Compounds.

Authors:  Bruno Melillo; Jochen Zoller; Bruce K Hua; Oscar Verho; Jannik C Borghs; Shawn D Nelson; Micah Maetani; Mathias J Wawer; Paul A Clemons; Stuart L Schreiber
Journal:  J Am Chem Soc       Date:  2018-09-06       Impact factor: 15.419

2.  Discovery of Key Physicochemical, Structural, and Spatial Properties of RNA-Targeted Bioactive Ligands.

Authors:  Brittany S Morgan; Jordan E Forte; Rebecca N Culver; Yuqi Zhang; Amanda E Hargrove
Journal:  Angew Chem Int Ed Engl       Date:  2017-09-18       Impact factor: 15.336

3.  Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells.

Authors:  Filip Roudnicky; Jitao David Zhang; Bo Kyoung Kim; Nikhil J Pandya; Yanjun Lan; Lisa Sach-Peltason; Heloise Ragelle; Pamela Strassburger; Sabine Gruener; Mirjana Lazendic; Sabine Uhles; Franco Revelant; Oliv Eidam; Gregor Sturm; Verena Kueppers; Klaus Christensen; Leonard D Goldstein; Manuel Tzouros; Balazs Banfai; Zora Modrusan; Martin Graf; Christoph Patsch; Mark Burcin; Claas A Meyer; Peter D Westenskow; Chad A Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-05       Impact factor: 11.205

Review 4.  Drug screening for human genetic diseases using iPSC models.

Authors:  Matthew S Elitt; Lilianne Barbar; Paul J Tesar
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

Review 5.  Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.

Authors:  Ashley N Matthew; Florian Leidner; Gordon J Lockbaum; Mina Henes; Jacqueto Zephyr; Shurong Hou; Desaboini Nageswara Rao; Jennifer Timm; Linah N Rusere; Debra A Ragland; Janet L Paulsen; Kristina Prachanronarong; Djade I Soumana; Ellen A Nalivaika; Nese Kurt Yilmaz; Akbar Ali; Celia A Schiffer
Journal:  Chem Rev       Date:  2021-01-07       Impact factor: 60.622

6.  The Use of Informer Sets in Screening: Perspectives on an Efficient Strategy to Identify New Probes.

Authors:  Paul A Clemons; Joshua A Bittker; Florence F Wagner; Allison Hands; Vlado Dančík; Stuart L Schreiber; Amit Choudhary; Bridget K Wagner
Journal:  SLAS Discov       Date:  2021-06-16       Impact factor: 3.341

7.  Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays.

Authors:  Jonathan A Lee; Paul Shinn; Susan Jaken; Sarah Oliver; Francis S Willard; Steven Heidler; Robert B Peery; Jennifer Oler; Shaoyou Chu; Noel Southall; Thomas S Dexheimer; Jeffrey Smallwood; Ruili Huang; Rajarshi Guha; Ajit Jadhav; Karen Cox; Christopher P Austin; Anton Simeonov; G Sitta Sittampalam; Saba Husain; Natalie Franklin; David J Wild; Jeremy J Yang; Jeffrey J Sutherland; Craig J Thomas
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells.

Authors:  Daniel R Stroik; Samantha L Yuen; Kevyn A Janicek; Tory M Schaaf; Ji Li; Delaine K Ceholski; Roger J Hajjar; Razvan L Cornea; David D Thomas
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

Review 9.  Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery.

Authors:  Ashutosh Kumar; Kam Y J Zhang
Journal:  Front Chem       Date:  2018-07-25       Impact factor: 5.221

10.  Green and Facile Assembly of Diverse Fused N-Heterocycles Using Gold-Catalyzed Cascade Reactions in Water.

Authors:  Xiuwen Jia; Pinyi Li; Xiaoyan Liu; Jiafu Lin; Yiwen Chu; Jinhai Yu; Jiang Wang; Hong Liu; Fei Zhao
Journal:  Molecules       Date:  2019-03-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.